Leaflet DEFUMOXAN 1.5mg tablets

Product code:
W66538001
Quantity:
100
Indicated for:
smoking cessation
Route of administration:
oral
Substance:
cytisine (cholinergic agonist)
ATC
N07BA04 — Nervous system | Drugs used in addictive disorders | Drugs used in nicotine dependence
Cytisine is a medication used for the treatment of nicotine addiction, helping patients quit smoking. It works by stimulating nicotinic receptors, reducing withdrawal symptoms and the urge to smoke.

The medication is taken orally, as directed by a doctor, usually over a period of several weeks. It is important for patients to follow the treatment regimen and combine the medication with psychological counseling to increase the chances of success.

Patients should be aware of potential side effects, such as nausea, insomnia, or irritability. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, insomnia, and irritability. In rare cases, severe reactions such as high blood pressure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about DEFUMOXAN 1.5mg

Substance:
cytisine
Date of latest medicines list:
01-03-2020
Product code:
W66538001
Concentration:
1.5mg
Pharmaceutical form:
tablets
Quantity:
100
Product type:
Generic medicine
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
AFLOFARM FARMACJA POLSKA SP. Z O.O. - POLONIA
Holder:
AFLOFARM FARMACJA POLSKA SP. Z O.O. - POLONIA
Number:
14735/2022/01
Shelf life:
18 months